Practical lessons for publishers

Putting patients first For decades, research publishing followed a fixed script. Researchers investigated. Publishers validated, polished and shared their findings. Patients, if mentioned, were the subjects of the research, not contributors to it. That model is shifting. Across the publishing industry, there’s growing recognition that ...

Companies may be misleading parents with “outrageous claims” about banking baby teeth

Experts alarmed by “outrageous” treatment claims for autism and diabetes Several claims to be reviewed by Advertising Standards Agency Parents are spending thousands of pounds to bank stem cells from their children’s milk teeth – but the recipient companies’ claims about their future medical value are unproven and potentially misleading, ...

2025-08-26T10:24:27+00:0026 August 2025|Press release, The BMJ|

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Recommendations account for varied patient risk profiles and focus on weight loss effects, particularly of drugs of interest to adults with concomitant obesity SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney ...

2025-08-15T14:49:00+00:0015 August 2025|Press release, The BMJ|

ADHD medication linked to reduced risk of suicide, drug abuse, transport accidents and criminal behaviour

Findings should help inform clinical practice and the debate on ADHD drug treatment Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviours, substance misuse, transport accidents, and criminality, finds a study published by The BMJ today. The researchers say this ...

2025-08-14T10:53:39+00:0014 August 2025|Press release, The BMJ|
Go to Top